HUM241220C262500
- 0.12
- 0.000.00%
Humana Newsroom
US Equities Markets End Higher Friday as Investors Evaluate Macro Data
Equities Rise Intraday as Traders Assess Macro Data
Baird Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $270
Unusual Options Activity: HIMS, FN and Others Attract Market Bets, HIMS V/OI Ratio Reaches 115.4
Government Shutdown Threat: Stocks Wobble, Holiday Travel And Paychecks Could Face Delays: What You Need To Know
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Express News | Humana Names Japan Mehta as Chief Information Officer
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts Humana Price Target to $270 From $374, Maintains Neutral Rating
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Stocks Down 10% or More: Humana, Marvell, and Amentum
Deutsche Says Humana Most at Risk From DOGE Targeting Medicare Overlap
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Clover Health Draws New Buy at Craig-Hallum Despite Sharp YTD Gains
Top Stock Movers Now: Amentum Holdings, Humana, Nvidia, and More
Humana Is Maintained at Equal-Weight by Morgan Stanley